GNS-212-E2

GNS-212-E2 is an investigational pharmaceutical agent being evaluated as a bowel preparation solution for colonoscopy procedures. It is part of the GNS-212-E series, which includes other formulations such as GNS-212-E1 and GNS-212-ER. The drug is administered to patients prior to colonoscopy to cleanse the bowel, thereby improving visualization during the procedure. The mechanism of action likely involves inducing bowel movements and promoting gastrointestinal cleansing, similar to other agents used for this indication; however, specific molecular targets or active ingredients have not been disclosed in public sources. Clinical trials are ongoing to assess its efficacy and safety compared with standard preparations[1][5].